UB
Verified User in Biotechnology
Senior Director Medical Affairs
Biotechnology
Mid-Market (51-1000 emp.)
For early discovery work, this reviewer finds the platform valuable in narrowing the design space before experimentation. Outputs still require experimental validation, and relying solely on in silico scores can lead to misplaced trust in the models.
View Full Review